SynAct Pharma AB Financial Overview
SynAct Pharma AB's market cap is currently €110.83M. The company's EPS TTM is €-0.061603200000000004; its P/E ratio is -10.49; SynAct Pharma AB is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
